Impact of caloric restriction in patients with multiple sclerosis treated with oral disease modifying therapy

被引：0

作者：

Verdiani, Alice ^{[1
]}

Pirronello, Marta ^{[1
]}

D'Orso, Silvia ^{[1
]}

Corbisiero, Silvia ^{[1
]}

Lista, Beatrice ^{[1
]}

Perini, Corinna ^{[1
]}

Guerrera, Gisella ^{[1
]}

Sambucci, Manolo ^{[1
]}

Misiti, Andrea ^{[1
]}

Buscarinu, Maria Chiara ^{[2
,3
]}

Buttari, Fabio ^{[4
]}

Ise, Federica ^{[5
]}

Micillo, Teresa ^{[5
]}

Fusco, Clorinda ^{[5
]}

Colamatteo, Alessandra ^{[5
]}

Lauritano, Gianluca ^{[4
]}

Picozza, Mario ^{[1
]}

Carbone, Fortunata ^{[5
]}

Quartuccio, Esmeralda ^{[6
]}

Matarese, Giuseppe ^{[5
]}

Centonze, Diego ^{[4
]}

Salvetti, Marco ^{[2
,3
]}

Gasperini, Claudio ^{[6
]}

Borsellino, Giovanna ^{[1
]}

Battistini, Luca ^{[1
]}

机构：

[1] Fdn Santa Lucia, Rome, Italy

[2] S Andrea Hosp, Neurol, Rome, Italy

[3] S Andrea Hosp, Ctr Expt Neurol Therapies Ctr, Rome, Italy

[4] IRCCS Neuromed, Unit Neurol, Pozzilli, Italy

[5] Consiglio Nazl Ric IEOS CNR, Ist Endocrinol & Oncol Sperimentale, Naples, Italy

[6] San Camillo Forlanini Hosp, Dept Neurol, Rome, Italy

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

521 - P3.0

引用

页码：1521 / 1521

页数：1

共 50 条

[1] Impact of disease modifying therapy on fatigue among multiple sclerosis patients
Elkhooly, Mahmoud
Raghib, Muhammad
Lazar, Emily
Lazar, Adam
Liaquat, Zaima
Martinez, Carla
Rube, Jacob
Bernitsas, Evanthia
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1028 - 1028
[2] ORAL DISEASE MODIFYING THERAPY FOR MULTIPLE SCLEROSIS; IS THIS THE NEW NORMAL?
Johnson, B. H.
VALUE IN HEALTH, 2015, 18 (03) : A290 - A291
[3] Adherence to oral disease-modifying therapy in multiple sclerosis patients: A systematic review
Yoon, Ee Ling
Cheong, Wing Loong
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 : 104 - 108
[4] Cognitive dysfunction in patients with multiple sclerosis treated with first line disease modifying therapy
Ozakbas, S.
Cinar, B. Piri
Kosehasanogullari, G.
Yigit, P.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 652 - 652
[5] Stopping Disease Modifying Therapy in Multiple Sclerosis Patients
Presas, Silvia
Vicente Hervas-Garcia, Jose
Ramo-Tello, Cristina
NEUROLOGY, 2016, 86
[6] Racial impact on use of disease - modifying therapy in multiple sclerosis
Hyland, M.
Stone, L. A.
MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S469 - S470
[7] Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies
Porwal, Mokshal H.
Salter, Amber
Patel, Dhruvkumar
Obeidat, Ahmed Z.
JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2022, 14
[8] Fingolimod: an Oral Disease-Modifying Therapy for Relapsing Multiple Sclerosis
Yeh, E. Ann
Weinstock-Guttman, B.
ADVANCES IN THERAPY, 2011, 28 (04) : 270 - 278
[9] Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis
E. Ann Yeh
B. Weinstock-Guttman
Advances in Therapy, 2011, 28 : 270 - 278
[10] Disease modifying therapy use in multiple sclerosis patients with comorbidities
Conway, D. S.
Planchon, S. M.
Ontaneda, D.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 878 - 878

← 1 2 3 4 5 →